Steering Committee

Name, Qualification

Role in study

Address

Anne-Katrin Sjølie, MD, Dr.Sci

Anne Katrin Sjolie

Biography

Chairperson
Ophthalmology

Department of Ophthalmology Odense University Hospital
Sdr. Boulevard 29
DK-5000 Odense C
Denmark

Rudy Bilous, MD, FRCP

Prof Rudy Bilous
Biography

Diabetology
Diabetologist

Academic Centre,
James Cook University Hospital,
Marton Road,
Middlesbrough, TS4
3BW, UK.

Nish Chaturvedi, MBBS, MSc, MRCP, MFPHM, MD

Biography

Diabetology
Epidemiology
Biostatistics

National Heart and Lung Institute
Imperial College
St Mary's Campus
59-61 North Wharf Road
London W2 1LA, UK

Ywonne Fox, BSc

Sponsoring company representative

AstraZeneca R&D Mölndal
S-431 83 MÖLNDAL
Sweden

John Fuller, MA, MBBS, FFPHM, FRCP

Prof John Fuller

Biography

Diabetology
Epidemiology

The Eurodiab Data Co-ordinating Centre
Dept. of Epidemiology and Public-Health
University College London
1–19 Torrington Place
London WC1E 6BT
UK

Michael George, BSc,
MRCP, MFPM

Sponsoring company representative

Takeda Global R&D Centre (Europe)
Arundel Great Court
2 Arundel Street
London, WC2R 3DA, UK

James Hainer, MD, PhD

Biography

Sponsoring company representative

AstraZeneca LP

C3C-122

1800 Concord Pike

Wilmington DE 19850-5437

USA

Ronald Klein, MD, MPH

Biography

Ophthalmology

Department of Ophthalmology University of Wisconsin
Rm 460 WARF
610 Walnut Street
Madison, WI 53705
USA

Trevor J. Orchard, MB, BCh

Diabetology
Epidemiology

Diabetes and Lipid Research University of Pittsburgh
3512 Fifth Avenue
Pittsburgh, PA 15213
USA

Hans-Henrik Parving, MD,
Dr.Sci

Biography

Diabetology
Nephrology

Department of Medical Endocrinology
Rigshospitalet, University Hospital of Copenhagen
Blegdamsvej 9
DK-2100 Copenhagen
Denmark

Massimo Porta, MD, PhD

Biography

Ophthalmology
Diabetology

Department of Internal Medicine
University of Turin
Corso AM Dogliotti 14
10126 Turin
Italy

Ingrid Warnold, PhD

Biography

Sponsoring company representative

AstraZeneca R&D Mölndal
S-431 83 MÖLNDAL
Sweden

Executive Committee

Name, Qualification	Role in study	Address
Anne-Katrin Sjølie, MD, Dr.Sci	Chairperson Ophthalmology	Department of Ophthalmology Odense University Hospital Sdr. Boulevard 29 DK-5000 Odense C Denmark

Nish Chaturvedi, MBBS, MSc, MRCP, MFPHM, MD	Diabetology Epidemiology Biostatistics	National Heart and Lung Institute Imperial College St Mary's Campus 59-61 North Wharf Road London W2 1LA, UK

Ywonne Fox, BSc	Sponsoring company representative	AstraZeneca R&D Mölndal S-431 83 MÖLNDAL Sweden

John Fuller, MA, MBBS, FFPHM, FRCP	Diabetology Epidemiology	The Eurodiab Data Co-ordinating Centre Dept. of Epidemiology and Public-Health University College London 1–19 Torrington Place London WC1E 6BT UK

Helen Walkey, PhD	Management of retinal assessments	National Heart and Lung Institute Imperial College St Mary's Campus 59-61 North Wharf Road London W2 1LA, UK

Michael George, BSc, MRCP, MFPM	Hypertension Diabetology Knowledge of candesartan	Takeda Global R&D Centre (Europe) Arundel Great Court 2 Arundel Street London, WC2R 3DA, UK

James Hainer, MD, PhD	Sponsoring company representative	AstraZeneca LP C3C-122 1800 Concord Pike Wilmington DE 19850-5437 USA

Ingrid Warnold, PhD	Sponsoring company representative	AstraZeneca R&D Mölndal S-431 83 MÖLNDAL Sweden

Graham Price BSc, MBBS, MFPM	Knowledge of candesartan	Takeda Global R&D Centre (Europe) Arundel Great Court 2 Arundel Street London, WC2R 3DA, UK

Independent Safety Committee

Name	Role in study	Address
Professor Lars Wilhelmsen	Chair Epidemiology	University of Gothenburg Section for Preventative Cardiology Drakegatan 6 SE-412 50 GÖTEBORG Sweden

Professor Alan Bird	Ophthalmology	Moorfields Eye Hospital City Road London EC1V 2PD UK

Professor Hans Wedel	Statistics	Apelsingatan 115 SE-426 54 VÄSTRA FRÖLUNDA Sweden

DIRECT Project team

Mr Steven Aldington (Retinopathy Grading Centre, Director)
Ms Susanne Arvidsson (AstraZeneca)
Mr Magnus Dahl (AstraZeneca)
Dr Aaron Deveney (Takeda)
Ms Elisabeth Adler-Ekholm (AstraZeneca)
Mr Richard Evans (Academic Coordinating Centre)
Ms Eva Karlsten (AstraZeneca)
Ms Carol Kavanagh (ICON Clinical Research)
Ms Philippa Levins (ICON, Project Director)
Ms Helen Lipinski (Retinopathy Grading Centre)
Ms Adeloa Osifeso (Takeda)
Mr Karel Pavka (ICON Clinical Research)
Ms Carol Prenter (ICON Clinical Research)
Dr Graham Price (Takeda, Deputy Project Leader)
Dr Helen Walkey (Academic Co-ordinating Centre, Project Manager)
Ms Nicola Walters (Quest Diagnostics, Project Manager)
Dr Ingrid Warnold (AstraZeneca, Project Leader)

International Coordinators Group

Professor Carl-David Agardh, Sweden
Professor Rudy Bilous, UK
Professor Francois Bonnici, South Africa
Professor Bernard Charbonnel, France
Professor Mark Cooper, Australia
Professor Ivan Dedov, Russia
Professor Robert Gardiner, Canada
Professor Ramon Gomis, Spain
Professor Hasan Ilkova, Turkey
Professor Nicholas Katsilambros, Greece
Professor Zsuzsa Kerenyi, Hungary
Professor Stephan Martin, Germany
Professor Pascale Massin, France
Professor Valdis Pirags, Baltic States
Professor Massimo Porta, Italy
Professor Itamar Raz, Israel
Professor Guntram Schernthaner, Austria
Professor Marina Shestakova, Russia
Professor Anne Katrin Sjølie, Denmark
Professor Krzysztof Strojek, Poland
Professor Zdeneck Rusavy, Czech Republic.

Programme Statistician

Dr Anders Malm